4.6 Article

Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: the TIARA study

期刊

BMJ OPEN
卷 8, 期 7, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2018-021531

关键词

eating disorders; neuromodulation; anorexia nervosa; repetitive transcranial magnetic stimulation (rTMS)

资金

  1. National Institute for Health Research (NIHR) Research for Patient Benefit (RfPB) [RB-PG-1013-32049]
  2. NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust (SLaM) and King's College London
  3. NIHR under its RfPB Programme [PB-PG-1013-32049]

向作者/读者索取更多资源

Objective Treatment options for severe, enduring anorexia nervosa (SE-AN) are limited. Non-invasive neuromodulation is a promising emerging intervention. Our study is a feasibility randomised controlled trial of repetitive transcranial magnetic stimulation (rTMS) in individuals with SE-AN, which aims to inform the design of a future large-scale trial. Design Double-blind, parallel group, two-arm, sham-controlled trial. Setting Specialist eating disorders centre. Participants Community-dwelling people with anorexia nervosa, an illness duration of >= 3 years and at least one previous completed treatment. Interventions Participants received 20 sessions (administered over 4 weeks) of MRI-guided real or sham high-frequency rTMS to the left dorsolateral prefrontal cortex in addition to treatment-as-usual. Outcomes Primary outcomes were recruitment, attendance and retention rates. Secondary outcomes included body mass index (BMI), eating disorder symptoms, mood, quality of life and rTMS safety and tolerability. Assessments were conducted at baseline, post-treatment and follow-up (ie, at 0 month, 1 month and 4 months post-randomisation). Results Thirty-four participants (17 per group) were randomly allocated to real or sham rTMS. One participant per group was withdrawn prior to the intervention due to safety concerns. Two participants (both receiving sham) did not complete the treatment. rTMS was safe and well tolerated. Between-group effect sizes of change scores (baseline to follow-up) were small for BMI (d=0.2, 95% CI-0.49 to 0.90) and eating disorder symptoms (d=0.1, 95% CI-0.60 to 0.79), medium for quality of life and moderate to large (d=0.61to 1.0) for mood outcomes, all favouring rTMS over sham. Conclusions The treatment protocol is feasible and acceptable to participants. Outcomes provide preliminary evidence for the therapeutic potential of rTMS in SE-AN. Largest effects were observed on variables assessing mood. This study supports the need for a larger confirmatory trial to evaluate the effectiveness of multi-session rTMS in SE-AN. Future studies should include a longer follow-up period and an assessment of cost-effectiveness.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据